Stocks · Health care · Biological Products, (No Diagnostic Substances)

Monte Rosa Therapeutics, Inc.

GLUE Clue Score47
United States Fiscal year ends December CIK 0001826457 Results filed 5 Nov 2026

What the insiders did Net selling

Nothing of that kind in this period.

What was left out

Form 4 filings counted 40
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 18
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 1,377,460
History held since 25 Jun 2021